+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hepatocellular Carcinoma"

From
Global Immuno-oncology Market - Product Thumbnail Image

Global Immuno-oncology Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Immuno-oncology Development Trends and Opportunities - Product Thumbnail Image

Immuno-oncology Development Trends and Opportunities

  • Report
  • November 2018
  • 258 Pages
  • Global
From
From
Advances in Cancer Research. Volume 152 - Product Thumbnail Image

Advances in Cancer Research. Volume 152

  • Book
  • August 2021
  • 312 Pages
Canine and Feline Liver Cytology. Edition No. 1 - Product Thumbnail Image

Canine and Feline Liver Cytology. Edition No. 1

  • Book
  • September 2023
  • 288 Pages
Canine and Feline Liver Cytology. Edition No. 1 - Product Thumbnail Image

Canine and Feline Liver Cytology. Edition No. 1

  • Book
  • September 2023
  • 288 Pages
Signaling Pathways in Liver Diseases. Edition No. 3 - Product Thumbnail Image

Signaling Pathways in Liver Diseases. Edition No. 3

  • Book
  • October 2015
  • 520 Pages
Viral Hepatitis. Edition No. 4 - Product Thumbnail Image

Viral Hepatitis. Edition No. 4

  • Book
  • October 2013
  • 624 Pages
Loading Indicator

Hepatocellular Carcinoma (HCC) is a type of cancer that originates in the liver. It is the most common form of liver cancer and is the third leading cause of cancer-related deaths worldwide. HCC is typically diagnosed in individuals with underlying liver diseases such as cirrhosis, hepatitis B or C, and non-alcoholic fatty liver disease. Treatment options for HCC include surgery, radiation therapy, chemotherapy, and targeted therapy. The oncology market for HCC is highly competitive, with a number of companies offering treatments and therapies. These include AbbVie, Bristol-Myers Squibb, Merck, Novartis, Pfizer, Roche, and Takeda. Additionally, there are a number of smaller companies that are developing novel therapies for HCC, such as Aduro Biotech, ArQule, and Oncoceutics. Show Less Read more